イベント

すべて表示
    Join BIOCYTOGEN at DivcoWest and BVS' Biotech Event at Cambridge Crossing

    Join BIOCYTOGEN at DivcoWest and BVS' Biotech Event at Cambridge Crossing

    June 25, 2025
    〜でシェア:

    Biocytogen is thrilled to participate as a vendor at the upcoming DivcoWest and BVS Biotech Event at Cambridge Crossing on Wednesday, June 25th, from 11:00 AM to 1:30 PM in Cambridge, MA. BVS is hosting this event with DivcoWest, which offers an excellent opportunity to connect with the biotech community. We’ll showcase our latest biopharma antibody drug development and innovative mouse models. Please stop by to meet our team and learn more. Let’s connect!

     

    What is DivcoWest and BVS' Biotech Event at Cambridge Crossing?

    DivcoWest and BVS are hosting a Biotech Event at Cambridge Crossing on Wednesday, June 25th, from 11:00 AM – 1:30 PM at 222 Jacobs Street, Cambridge, MA. This indoor event will feature vendor exhibits, food, drinks, and exciting raffle prizes and is open to all DivcoWest tenants. Don’t miss this excellent opportunity to network and connect with the biotech community!

     

    Event Overview

    Date: June 25, 2025 11:00 AM - 1:30 PM

    Venue: Cambridge Crossing, 222 Jacobs Street, Cambridge, MA

    Event Schedule

    This event will be held in a life science and technology building in Cambridge Crossing from 11am to 1pm on June 25th. For more event details, please refer to BVS Cambridge Crossing.

     

    About BIOCYTOGEN

    Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).

     

    We look forward to chatting with you at the DivcoWest and BVS' Biotech Event at Cambridge Crossing in Cambridge, MA!